EXAGEN INC. (XGN) Insider Trading & SEC Filings
Last SEC filing
EXAGEN INC. (XGN) has filed 3 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-22. 2 Form 8-K material event filings were reported by XGN in the last 90 days. InsiderAlpha tracks every XGN SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About EXAGEN INC. (XGN)
EXAGEN INC. trades under the ticker XGN. InsiderAlpha tracks 18 primary SEC Form 4 filings from 9 reporting insiders for XGN since 2024, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Services-Medical Laboratories (SIC 8071) |
| SEC CIK | 0001274737 |
90-Day SEC Filing Activity
| Form 4 filings (90d) | 3 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Latest Form 4 filing | 2026-06-22 |
Recent XGN Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jeffrey G. Black | Chief Financial Officer | A - Grant or award | 75.0K | $3.16 | $237K | SEC | |
| John Aballi | President and CEO | A - Grant or award | 150.0K | $0.00 | - | SEC | |
| John Aballi | President and CEO | A - Grant or award | 2.5K | $3.08 | $8K | SEC | |
| John Aballi | President and CEO | S - Open-market sale | 15.7K | $3.62 | $57K | SEC | |
| Jeffrey G. Black | Chief Financial Officer | A - Grant or award | 1.5K | $3.08 | $5K | SEC | |
| John Aballi | President and CEO | S - Open-market sale | 11.4K | $3.61 | $41K | SEC | |
| Jeffrey G. Black | Chief Financial Officer | S - Open-market sale | 1.6K | $3.61 | $6K | SEC | |
| John Aballi | President and CEO | S - Open-market sale | 31.8K | $11.82 | $376K | SEC | |
| Jeffrey G. Black | Chief Financial Officer | S - Open-market sale | 20.5K | $9.79 | $200K | SEC | |
| NMSIC Co-Investment Fund, L.P. | Insider | S - Open-market sale | 200.0K | $3.30 | $660K | SEC | |
| Jeffrey G. Black | Chief Financial Officer | P - Open-market purchase | 22.3K | $2.98 | $66K | SEC | |
| John Aballi | President and CEO | P - Open-market purchase | 24.3K | $2.81 | $68K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for EXAGEN INC. (XGN). Updated in real time as new filings are submitted to the SEC.
Most-Active XGN Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Frank Stokes | 1 | - |
| Scott D. Kahn | 1 | - |
| Chas McKhann | 1 | - |
Recent XGN Form 8-K Material Events
- - Item 5.07 [SEC]
- - Item 2.02, 9.01 [SEC]
- - Item 5.02, 9.01 · Leadership · neutral [SEC]
Ana Hooker resigned from the Board of Directors of Exagen Inc. effective April 17, 2026, reducing the board size from 8 to 7 members. Ms. Hooker was a member of the Audit Committee and chair of the Nominating and Corporate Governance Committee. Her resignation was not due to any - - Item 2.02, 9.01 · Earnings · neutral [SEC]
Exagen Inc. reported its financial results for the quarter and year ended December 31, 2025 on March 10, 2026. The filing provides standard quarterly and annual financial results without specific beat/miss language or forward guidance changes.
Recent Insider Filings
- - Scott D. Kahn (Director)
- - Chas McKhann (Director)
- - Frank Stokes (Director)
- - Jeffrey G. Black (Chief Financial Officer)
- - John Aballi (President and CEO)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in XGN insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
XGN Insider Trading - FAQ
- What is the latest insider trade for XGN?
- EXAGEN INC. (XGN) had 3 insider filings in the last 90 days, with the most recent on 2026-06-22. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying XGN stock?
- 0 insider purchases of XGN were filed in the last 90 days.
- How many insiders are selling XGN stock?
- 0 insider sales of XGN were filed in the last 90 days.
- Where can I see XGN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks XGN Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $ZBIO Zenas BioPharma, Inc.
- $ZURA Zura Bio Ltd
- $ZYME Zymeworks Inc.
- $ABP Abpro Holdings, Inc.
- $AEMD AETHLON MEDICAL INC
- $AHCO AdaptHealth Corp.
- $AIM AIM ImmunoTech Inc.
- $AKTX Akari Therapeutics Plc
- $ALMS ALUMIS INC.
- $ANNX Annexon, Inc.
Related Companies - Recent Insider Activity
- Guardant Health, Inc. (GH)
- Natera, Inc. (NTRA)
- CASTLE BIOSCIENCES INC (CSTL)
- QUEST DIAGNOSTICS INC (DGX)
- SERA PROGNOSTICS, INC. (SERA)
- CareDx, Inc. (CDNA)
- VERACYTE, INC. (VCYT)
- Personalis, Inc. (PSNL)
- Fulgent Genetics, Inc. (FLGT)
- Celcuity Inc. (CELC)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live XGN dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.